| SpectraBase Spectrum ID |
2pRvFiDl0rI |
| Name |
2F-3,4-MDA TMS |
| Classification |
Amphetamine designer drug derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
269.124733584 u |
| Formula |
C13H20FNO2Si |
| InChI |
InChI=1S/C13H20FNO2Si/c1-9(15-18(2,3)4)7-10-5-6-11-13(12(10)14)17-8-16-11/h5-6,9,15H,7-8H2,1-4H3 |
| InChIKey |
NMRFPBRYTCRRGG-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
269.391 g/mol |
| Nominal Mass |
269 u |
| Quality |
998 |
| Retention Index |
1648 |
| SMILES |
C12=C(C(CC(N[Si](C)(C)C)C)=CC=C2OCO1)F |
| SPLASH |
splash10-01b9-5900000000-442b4660263bdef87ffb |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
2F-MDA TFA
2-Fluoro-3,4-methylenedioxyamphetamine TMS
N-(1-(4-fluoro-1,3-benzodioxol-5-yl)propan-2-yl)(trimethyl)silanamine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_018836 |
